Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Clinical Reasoning Vs. Documentation: The Next Battleground for Medical LLMs
The first wave of healthcare AI delivered clear ROI by automating clinical documentation, turning high‑entropy encounter notes into structured, billable outputs. Vendors like Nuance DAX, Abridge, and Epic have made ambient scribes a table‑stake feature, driving productivity gains of several minutes per note. That compression‑focused market is now saturating, compressing margins and limiting differentiation. The next frontier is augmenting clinical reasoning—a fundamentally inference‑driven problem that current large language models only partially satisfy.
Mindray North America Enters Ventilator Market
Mindray North America announced the launch of its SV900 and SV700 ventilators, marking the company’s entry into the U.S. respiratory‑care market. As the world’s second‑largest acute‑care ventilator supplier, Mindray is expanding its critical‑care portfolio with devices that combine invasive, non‑invasive...
NYS Targets Tobacco Companies
The New York State Department of Health’s Bureau of Tobacco Control has issued an RFP for a public‑relations firm to design a statewide campaign exposing the tobacco industry’s role in the ongoing epidemic. The initiative will spotlight the industry’s impact...
Three Numbers That Could Prevent the Next Health Emergency
The 7-1-7 framework sets three time‑bound targets—detect an outbreak within seven days, notify authorities within one day, and launch essential response actions within the next seven days. A Lancet Global Health analysis of 41 events in five African nations found...
Off the Scales: The Inside Story of Ozempic and the Race to Cure Obesity Reviewed
The review of Aimee Donnellan’s book Off the Scales examines how Ozempic, a GLP‑1 drug originally for type‑2 diabetes, has become a blockbuster obesity treatment. It details the drug’s ability to deliver rapid 20%‑plus weight loss, its side‑effect profile, and...
Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
Perfuze obtained FDA 510(k) clearance for its Millipede88 Aspiration Catheter after the MARRS clinical study met all primary objectives. The device is the first super‑bore 0.088 catheter cleared for standalone direct aspiration, featuring a patented corrugated design that preserves lumen...
EMR Optimization: Why Ambient AI Can’t Fix a Broken EHR
The panel discussed practical approaches to EMR/EHR optimization, emphasizing that hidden workflow friction—not just software bugs—drives clinician burnout. They highlighted the need for combined quantitative analytics (e.g., usage dashboards, sentiment analysis) and qualitative methods (shadowing, listening sessions) to surface problems,...
Roche Ends Run for Muscular Atrophy Drug, Leaving Door Open for Competitors
Roche announced it will discontinue development of its anti‑myostatin antibody emugrobart for spinal muscular atrophy (SMA) after the Phase 2/3 MANATEE trial failed to demonstrate consistent muscle‑growth or motor‑function benefits. The study enrolled 259 patients and compared emugrobart plus Evrysdi against...
Rhythm Obesity Drug Wins Broader Use From FDA
The FDA approved Rhythm Pharmaceuticals' once‑daily injection Imcivree for acquired hypothalamic obesity in adults and children aged four and up. Clinical trials showed an 18‑percentage‑point weight‑loss advantage over placebo, making it the first therapy for this rare, brain‑injury‑driven condition. Rhythm...
Why Respiratory Device Hygiene Is Becoming a Bigger Healthcare Conversation
Respiratory support devices such as CPAP are increasingly used in home health settings, shifting maintenance responsibilities to patients. Poor hygiene—mask oil, tubing moisture, mineral deposits, and clogged filters—gradually degrades performance and can cause therapy abandonment. Automated UV‑C and ozone sanitizing...
Benefits Lessons to Learn From a Brutal Flu Season
The 2024‑2025 flu season has been unusually severe, with the CDC reporting 78 million cases, over a million hospitalizations and 67 000 deaths. Antiviral prescriptions are up 24% compared with the previous year, and Evernorth’s MD Live saw a 400% surge in flu‑related...
Re: Prognostic Score for Predicting Respiratory Admissions Among Patients with Chronic Obstructive Pulmonary Disease in Primary Care: Development and Validation...
Physicians Di Micco and Siniscalchi commend the BLISS prognostic score, which estimates two‑year respiratory admissions for COPD patients in primary care. They argue that real‑world outcomes are heavily influenced by acute comorbidities such as pulmonary embolism, COVID‑19, and cancer, as well...
LinusBio Expands Its Laser-Powered Hair Test to Help Rule Out Autism in Older Children
LinusBio has broadened its ClearStrand‑ASD hair‑based screening to children up to ten years old, extending beyond the original under‑48‑month validation. The test analyzes a single strand of hair with proprietary robotics and laser technology to detect metabolic patterns linked to...
Genentech Culls Muscle-Preserving Drug in Genetic Diseases, Raising Questions About Obesity Trial
Roche’s Genentech has halted the Phase III development of its muscle‑preserving therapy for spinal muscular atrophy (SMA) and facioscapulohumeral muscular dystrophy (FSHD). The decision follows disappointing efficacy signals and safety concerns that emerged in late‑stage trials. The program also included an...
Appeal Finds NICE Must Reconsider Alzheimer's Drugs
NICE has agreed to revisit its June 2025 rejection of Eli Lilly’s Kisunla (donanemab) and Eisai’s Leqembi (lecanemab) for NHS reimbursement. The appeal will send the dossiers back to the appraisal committee to re‑examine clinical benefits, long‑term data, infusion costs and unpaid...
"Stay Home, Protect the NHS" May Have Cost Lives: Inquiry Stops Short – My Book Exposes the Full Truth
The UK Covid Inquiry’s Module 3 report, released on 19 March 2026, concluded that the "Stay Home, Protect the NHS" slogan likely discouraged people from seeking urgent medical care, contributing to avoidable non‑COVID deaths. The inquiry highlighted a sharp drop in A&E attendances,...
How CNBC Cures Is Bringing Rare Disease Stories to a National Audience
CNBC Cures, launched on Jan 8, 2026 by "Squawk Box" co‑host Becky Quick, is the network’s dedicated platform for rare‑disease awareness. Within two months it has produced a weekly newsletter, a podcast series, a live summit, and a prime‑time documentary titled “CNBC...
Rady Children’s Hospital Stops Trans Care for Minors, Faces Lawsuits and DOJ Scrutiny
San Diego’s Rady Children’s Hospital halted gender‑affirming care for patients under 19, prompting four family lawsuits and a California Attorney General suit alleging breach of a 2034 merger agreement. The move adds to a wave of federal and state actions,...
Population Health Analytics Now Embedded Across Almost 9 Million NHS Patients, Supporting Earlier Intervention and Reduced Emergency Care
Population health analytics using the Johns Hopkins ACG® System are now embedded across nearly 9 million NHS patients, roughly one in six people in England, via Graphnet Health platforms. This shift moves analytics from planning to routine operational use across Integrated...
Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy
Johns Hopkins researchers introduced the Epigenetic Instability Index (EII), a metric that quantifies DNA methylation variability to enhance liquid biopsy performance. In a proof‑of‑concept study of over 2,000 methylation samples, the EII model identified 269 CpG islands and achieved high...
A Brief History of AI in Healthcare W/ Lekan Wang, Partner, JSL Health Capital
In this episode, John Driscoll chats with Lekan Wang, a partner at AI‑first venture fund JSL Health Capital, about the evolution of artificial intelligence in healthcare. Wang traces his journey from early work at Palantir integrating disparate health data for...
Photo of the Week: Del. Mobile EMS Outreach
New Castle County EMS has transformed a retired frontline ambulance into a dedicated mobile community outreach vehicle. The repurposed truck now houses tables, tents, CPR mannequins and informational materials, allowing the outreach team to drive straight to events without additional...
Re: Tessa Richards: BMJ Editor Who Championed Patients
The letter honors Tessa Richards for reshaping the BMJ’s approach to patient involvement, turning the journal into a global exemplar of patient partnership. Her early advocacy led to patient editors, peer reviewers, and mandatory PPI statements becoming integral to BMJ’s...
Shionogi Enrols First Patients in Esprit Trial for Pompe Disease
Shionogi announced the first patient enrollment in its global Phase II Esprit trial, evaluating the oral substrate‑reduction therapy S‑606001 in adults with late‑onset Pompe disease. The 52‑week, double‑blind, placebo‑controlled study will run across the EU, the UK and the United States,...
How New Mexico Became an Obamacare Success Story
After the federal enhanced ACA subsidies expired, New Mexico became the only state to replace them with state‑funded assistance. The move averted an estimated 27,000 residents losing coverage and added roughly 10,000 new enrollees, setting a record for the state...
First-of-Its-Kind Implant Could Transform Tissue Loss Treatment
Researchers at Technion’s Levenberg Laboratory have created a first‑of‑its‑kind three‑dimensional implant that merges muscle, fat, a hierarchical blood vessel network and, uniquely, a lymphatic system. The construct is printed with a custom extracellular‑matrix bio‑ink and matured in a flow‑controlled bioreactor....
Listen: Trump’s NIH ‘Reset’ Is Driving Away Scientists
The National Institutes of Health has seen roughly 20% of its workforce depart during President Trump’s second term, driven by budget cuts and a politically charged environment. Former NIH scientists warn that this exodus—often called a brain drain—could curtail breakthrough...
Mind-Altering Substances Are (Still) Falling Short in Clinical Trials
Psychedelic research has surged, but recent psilocybin trials reveal modest benefits that fail to outpace placebo. A German study with 144 treatment‑resistant depression patients found no statistically significant advantage for high‑dose psilocybin. An open‑label review of 24 trials concluded psychedelics...
Strategies for Smooth Transactions in Healthcare E-Commerce Platforms
Healthcare e‑commerce is expanding rapidly, but its transactions must juggle payment security, regulatory compliance, prescription verification, and complex logistics. The article outlines eight strategic pillars—including PCI DSS‑compliant checkout, end‑to‑end encryption, AI‑driven order validation, cold‑chain shipping, and seamless EHR integration—to create...
Mass CVD Screening Initiative Launches in Greater Manchester as Death Rate Exceeds Twice the National Average
PocDoc and The Brooke Surgery in Hyde have launched a week‑long mass cardiovascular disease (CVD) screening program in Greater Manchester, deploying a mobile Neighbourhood Testing Bus to reach 1,000 patients between 2‑9 March. The region records the highest CVD death...
Vaccines Work. Here’s Why We Care About Your Unvaccinated Child.
The article underscores that measles remains deadly despite overall vaccine success, citing recent tragedies—including a child who died from subacute sclerosing panencephalitis and another who suffered severe encephalitis. It highlights how unvaccinated or under‑vaccinated children, as well as those with...
Asda Pharmacy Offers Meningitis B Vaccine at Cost Price
Asda Pharmacy is providing the meningitis B (MenB) vaccine at cost price—£75 per dose or £150 for the two‑dose course—until 30 April, a steep discount from the usual £179.96. The rollout covers all 242 Asda pharmacies across the UK and prioritises vulnerable...
XCath Integrates NVIDIA Isaac for Healthcare to Advance Telerobotic Endovascular Systems
XCath is integrating NVIDIA Isaac for Healthcare into its autonomous telerobotic endovascular platform, creating digital twins of the robot, treatment devices, and patient vasculature. The digital‑twin rehearsal lets surgeons practice on a patient‑specific 3‑D model before the actual mechanical thrombectomy,...
Kéré Architecture Designs Healthcare Center in Burundi Using Regional Materials and Community-Based Construction
Kéré Architecture is designing a 3,000 m² healthcare centre in Burundi’s Bubanza region, using ten pavilions that follow the hillside terrain. The clinic, commissioned by NGO Ineza Clinic, focuses on maternity and specialized surgical care and relies on locally sourced clay...
Can Crisis Planning Reduce Repeat Sectioning? FINCH Feasibility Trial
FINCH, a feasibility trial of an advanced crisis‑planning intervention, recruited 80 detained patients across three NHS trusts and met its recruitment and diversity targets within nine months. Participants received ongoing, clinician‑facilitated planning, though only two‑thirds achieved the minimum dose due...
Why Health Systems Are Outsourcing Tech Support to Drive Adoption
Health systems are turning to outsourced tech support to boost patient portal adoption, as only 15%‑30% of patients currently use portal features. The primary barrier is not the technology but the lack of accessible, multilingual assistance for diverse patient populations....
![[Perspectives] Claire Calderwood: Integrated Health Screening for Tuberculosis](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/c234de0d49ef1ed6ce99bbd8a842690a.webp)
[Perspectives] Claire Calderwood: Integrated Health Screening for Tuberculosis
Claire Calderwood, an academic respiratory physician, argues for integrated health screening to combat tuberculosis. She highlights that respiratory disease prevention is intertwined with social and structural determinants of health. Calderwood’s work bridges clinical practice in the UK with research collaborations...
![[Comment] Should We Keep Pushing a High Fluid Intake in Kidney Stones?](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/71728300caabf9cdd7e72489bb93c7ec.webp)
[Comment] Should We Keep Pushing a High Fluid Intake in Kidney Stones?
High fluid intake remains the cornerstone for preventing kidney stones, yet patient adherence is consistently low. Systematic reviews and a recent 2026 randomized trial confirm that adequate hydration reduces stone recurrence, but practical, behavioral, and environmental barriers limit real‑world effectiveness....
UCLA Interventional Radiologist 1st to Perform 'Breakthrough' Procedure
UCLA interventional radiologist Edward Lee performed the first percutaneous spleno‑renal shunt on a 6‑year‑old boy suffering severe portal hypertension. The minimally invasive procedure relieved the child’s blocked portal vein, stopping recurrent bleeding episodes that had threatened his life. Lee’s success...
Type 1 Diabetes Linked to Significantly Higher Dementia Risk, Large U.S. Study Finds
A large U.S. cohort study using the All of Us Research Program found that people with type 1 diabetes are nearly three times as likely to develop dementia, while those with type 2 diabetes face about double the risk compared with non‑diabetics....
NIH Invests $150 Million in Human-Based Research to Reduce Use of Animal Models
The National Institutes of Health announced a $150 million investment in the new Complement‑ARIE program to develop and standardize human‑focused research tools, known as new approach methodologies (NAMs). The initiative will fund technology development centers, a data hub, and a validation...
Joint Commission A360 Compliance Check In
Tom Grice and Sharon Tyrell discuss the upcoming Joint Commission Accreditation 360 (A360) that takes effect on January 1, 2026, outlining its consolidation of the Environment of Care and Life Safety chapters into a single Physical Environment chapter and the...
Kaufman Hall January 2026 Report: Hospital Labor Expenses and Bad Debt Continue to Rise
Kaufman Hall’s January 2026 National Hospital Flash Report shows a sharp contraction in profitability, with the median operating margin falling to 2.1% from 4.9% a month earlier. Patient volumes slipped in both inpatient and outpatient settings, while labor expenses surged...
OpenClaw Enables Continuous Self‑Prompting AI for Healthcare
Some experts do not think OpenClaw is relevant to AI in healthcare. They are wrong. OpenClaw represents us phase shifting in the way we relate to AI systems again. We are moving past promting a chatbot to ask a question so...
Rebuilding Vaccine Trust After Ideologically Flawed ACIP Recommendations
Good news for America’s children. ACIP was devoid of vaccine expertise and made harmful and ideologically driven recommendations that went against pediatric medical science. Hopefully we can rebuild pubic confidence in vaccines despite their efforts to undermine it, but it...
Modifying T Cell Receptor Improves Targeted Cancer Therapy
Researchers from UCLA, Stanford, Utah, and Columbia have engineered T cell receptors to strengthen catch‑bond interactions with prostate cancer antigens, improving cytotoxic function. By altering just one or two amino acids in the TCR, the modified cells exhibit longer bond...
Re: Medical Training Prioritisation Bill Passes but Clarification Still Needed on IMGs, Leaders Say
The Medical Training (Prioritisation) Act 2026 has been enacted, establishing training‑place priority based on where doctors studied rather than citizenship. In 2025, 25,257 overseas‑trained doctors competed with 15,723 UK‑trained doctors for just 12,833 posts, highlighting a strained recruitment pipeline. The...
Turmoil at ACIP Continues After Claim Committee ‘Disbanded’ Is Quickly Refuted
An outspoken CDC Advisory Committee on Immunization Practices (ACIP) member claimed Thursday that the vaccine advisory group had been disbanded. The CDC quickly refuted the allegation, confirming that ACIP remains fully operational and continues its role in shaping U.S. immunization...
Hydration Doesn't Reduce Kidney Stone Recurrence, Study Finds
If you've had a kidney stone, you've been advised that the most important thing to prevent another bout is to increase hydration. Now a randomized trial of hydration in over 1600 participants showed no benefit, despite evidence of increase...
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-112061479-56a584f15f9b58b7d0dd41be.jpg)
Managing Claustrophobia During Medical Procedures
Claustrophobia can deter patients from essential imaging such as MRI, CT, PET, and bone scans, risking delayed diagnoses. The article outlines how fear arises from enclosed machines, loud noises, and restraints, and details treatment options including medication, psychotherapy, and exposure...